Human Reproduction Update最新文献

筛选
英文 中文
From folate to the epigenetic clock: one-carbon metabolism in oocyte quality and ovarian ageing. 从叶酸到表观遗传时钟:卵母细胞质量中的单碳代谢和卵巢老化。
IF 20.1 1区 医学
Human Reproduction Update Pub Date : 2026-11-06 DOI: 10.1093/humupd/dmag034
Xiaoqian Fu, Yihua Yang, Li Jiang, Qianyi Huang, Liyan Huang, Shuling Wang, Zhenghong Chen, Min Lu, Weiling Tang, Jingwen Chen, Huimei Wu, Lidan Liu
{"title":"From folate to the epigenetic clock: one-carbon metabolism in oocyte quality and ovarian ageing.","authors":"Xiaoqian Fu, Yihua Yang, Li Jiang, Qianyi Huang, Liyan Huang, Shuling Wang, Zhenghong Chen, Min Lu, Weiling Tang, Jingwen Chen, Huimei Wu, Lidan Liu","doi":"10.1093/humupd/dmag034","DOIUrl":"https://doi.org/10.1093/humupd/dmag034","url":null,"abstract":"<p><strong>Background: </strong>One-carbon metabolism (OCM) supports nucleotide synthesis and S-adenosylmethionine (SAM)-dependent methylation; its links to sulfur metabolism connect it to glutathione (GSH) synthesis and hydrogen sulfide (H2S) signalling. These functions are relevant to oocyte growth, epigenetic programming, and developmental competence, but their contribution to ovarian ageing remains incompletely understood. Existing reviews address pregnancy, embryo development, or female fertility broadly, leaving OCM in stage-specific oocyte biology and ageing insufficiently integrated.</p><p><strong>Objective and rationale: </strong>This review examines OCM in oocyte development, epigenetic regulation, and ovarian ageing, focusing on substrate supply, enzyme regulation, and methyl-donor metabolism. It evaluates experimental and clinical evidence on metabolic disturbances and nutritional interventions, and identifies knowledge gaps that limit clinical translation.</p><p><strong>Search methods: </strong>PubMed/MEDLINE was searched for English-language literature published from January 2008 to September 2026. OCM substrate, enzyme, and methylation terms were combined with oocyte, follicular, ovarian, embryo, and ART terms. Reference lists were hand-searched. Evidence was assessed by species, tissue, design, and outcome, prioritizing mechanistic perturbations, prospective cohorts, and clinical trials.</p><p><strong>Outcomes: </strong>Mouse studies indicate transient leucovorin uptake in growing oocytes and cumulus-supported serine transfer. Methylenetetrahydrofolate reductase (MTHFR) phosphorylation shows developmental regulation, whereas methionine adenosyltransferase 2A (MAT2A) inhibition after the eight-cell stage reduces bovine blastocyst development. DNA methylation supports imprint establishment; reducing methionine from 50 to 10 µM in bovine embryo culture altered methylation at more than 1600 genes. Porcine homocysteine (Hcy) exposure impaired mitochondrial and developmental endpoints, with an increased mitochondrial DNA 16S methylation signal whose causal role requires validation. Multi-component supplementation containing 5-methyltetrahydrofolate (5-MTHF) increased bovine blastocyst yield during maturation (34.9% vs 17.1%), without establishing a human protocol. In a selected recurrent-miscarriage/repeated-ART-failure cohort, over 40% were homozygous or compound heterozygous for common MTHFR variants, without appropriate controls establishing enrichment. Higher Hcy was associated with poorer implantation and clinical pregnancy in C677T TT carriers; a separate retrospective cohort associated hyperhomocysteinaemia with lower live birth (adjusted odds ratio [OR] approximately 0.45). Another retrospective study associated combined 5-MTHF/B12/B6 supplementation with higher clinical pregnancy (OR 2.03) and live birth (OR 1.83) than folic acid alone, without establishing causality. One study found optimal red-cell folate in 12% and adequate ","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":" ","pages":""},"PeriodicalIF":20.1,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149344758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes of Day-7 blastocysts: a systematic review and meta-analysis. 第7天囊胚的临床结果:一项系统回顾和荟萃分析。
IF 20.1 1区 医学
Human Reproduction Update Pub Date : 2026-11-01 DOI: 10.1093/humupd/dmag017
Julie Firmin, Bastien Ducreux, Haitam Saidessalam, Lucile Ferreux, Khaled Pocate-Cheriet, Ahmed Chargui, Chloé Maignien, Mathilde Bourdon, Pietro Santulli, Catherine Patrat, Patricia Fauque
{"title":"Clinical outcomes of Day-7 blastocysts: a systematic review and meta-analysis.","authors":"Julie Firmin, Bastien Ducreux, Haitam Saidessalam, Lucile Ferreux, Khaled Pocate-Cheriet, Ahmed Chargui, Chloé Maignien, Mathilde Bourdon, Pietro Santulli, Catherine Patrat, Patricia Fauque","doi":"10.1093/humupd/dmag017","DOIUrl":"10.1093/humupd/dmag017","url":null,"abstract":"<p><strong>Background: </strong>Extended embryo culture beyond Day-6 remains controversial. While a small subset of embryos reaches the blastocyst stage on Day-7, their developmental competence and reproductive potential remain uncertain. Data from previous studies have been limited and heterogeneous, particularly for meta-analytical evaluation of euploid embryo transfers.</p><p><strong>Objective and rationale: </strong>This systematic review and meta-analysis compared clinical pregnancy (CPR) and live birth rates (LBR), as well as implantation (IR), miscarriage (MR), and ongoing pregnancy rates (OPR), between Day-7 frozen blastocysts and those obtained on Day-5 and/or Day-6. Euploidy rates by day of blastocyst development and available perinatal outcomes were also assessed.</p><p><strong>Search methods: </strong>Conducted according to PRISMA guidelines, this review included full-length English-language human studies, published up to 1 April 2026, comparing frozen transfers of Day-7 versus Day-5/6 blastocysts and reporting at least clinical pregnancy and/or live birth outcomes. Random-effects models were used to estimate pooled odds ratios (ORs) with 95% confidence intervals (95% CI). Obstetric and perinatal outcomes were analysed when available.</p><p><strong>Outcomes: </strong>A total of 17 retrospective studies were included. Across 2908 Day-7 transfers, CPR and LBR were significantly lower than for Day-5 (CPR: OR 0.26, 95% CI 0.19-0.35, I2: 76.2%, 16 studies, 2799 and 34 442 transfers at Day-7 and Day-5, respectively; LBR: OR 0.23, 95% CI 0.16-0.33, I2: 76.3%, 12 studies, 2687 and 31 630 transfers at Day-7 and Day-5, respectively) and Day-6 blastocysts (CPR: OR 0.38, 95% CI 0.31-0.48, I2: 54.4%, 16 studies, 2799 and 28 563 transfers at Day-7 and Day-6, respectively; LBR: OR 0.37, 95% CI 0.28-0.49, I2: 60.2%, 12 studies, 2687 and 26 687 transfers at Day-7 and Day-6, respectively). Similarly, IR and OPR were significantly lower in the Day-7 group than in the Day-5 or Day-6 groups, while MR was higher compared with Day-5 blastocysts (OR 1.54, 95% CI 1.04-2.30, I2: 51.1%, 14 studies, 685 and 18 609 pregnancies at Day-7 and Day-5, respectively). When considering only PGT-A euploid blastocysts, CPR and LBR remained significantly lower in the Day-7 group compared with Day-5 (CPR: OR 0.21, 95% CI 0.14-0.33, I2: 58.0%, 7 studies, 365 and 7064 transfers at Day-7 and Day-5, respectively; LBR: OR 0.21, 95% CI 0.17-0.28, I2: 0%, 6 studies, 364 and 5924 transfers at Day-7 and Day-5, respectively) and Day-6 (CPR: OR 0.36, 95% CI 0.28-0.46, I2: 40.8%, 7 studies, 365 and 4617 transfers at Day-7 and Day-6, respectively; LBR: OR 0.36, 95% CI 0.28-0.46, I2: 0%, 6 studies, 364 and 3782 transfers at Day-7 and Day-6, respectively), and MR was higher than Day-5 (OR 2.78, 95% CI 1.57-4.89, I2: 32.4%, 6 studies, 95 and 4018 pregnancies at Day-7 and Day-5, respectively). Euploid rates were also significantly reduced for Day-7 blastocysts compared with Day-5 and Day-6. ","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":" ","pages":"717-734"},"PeriodicalIF":20.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endometriosis-related peritoneal adhesion formation: molecular mechanisms and clinical significance. 子宫内膜异位症相关腹膜粘连形成:分子机制及临床意义。
IF 20.1 1区 医学
Human Reproduction Update Pub Date : 2026-11-01 DOI: 10.1093/humupd/dmag021
Becky Macpherson, Joel Zindel, Michael Mueller, Erin Greaves
{"title":"Endometriosis-related peritoneal adhesion formation: molecular mechanisms and clinical significance.","authors":"Becky Macpherson, Joel Zindel, Michael Mueller, Erin Greaves","doi":"10.1093/humupd/dmag021","DOIUrl":"10.1093/humupd/dmag021","url":null,"abstract":"<p><strong>Background: </strong>Peritoneal adhesions are a major and often under-recognized cause of morbidity following abdominopelvic inflammation and surgery, contributing to chronic pelvic pain, infertility, bowel obstruction, and surgical complications. Endometriosis, affecting 10-11% of reproductive-age women, is strongly associated with adhesions; however, whether adhesion formation in endometriosis reflects general peritoneal injury or disease-specific mechanisms remains unclear.</p><p><strong>Objective and rationale: </strong>This narrative review examines (i) physiological peritoneal healing and mechanisms of adhesion formation, (ii) how the altered peritoneal microenvironment in endometriosis may modify adhesiogenesis, and (iii) current and theoretical therapeutic and preventative strategies for adhesions in endometriosis. This will improve current understanding of adhesiogenesis and the implications of adhesions in women with endometriosis, and will identify areas for future research to reduce morbidity in this patient population.</p><p><strong>Search methods: </strong>Literature searches were performed in PubMed, Embase and Cochrane Library using combinations of the terms 'endometriosis', 'adhesions', 'pelvic', 'abdominal', 'peritoneal' between January 2000 and February 2026. Randomized-controlled trials, observational studies, systematic reviews, and relevant experimental studies were included. Case reports and non-English publications were excluded. A total of 124 studies were included in this literature review.</p><p><strong>Outcomes: </strong>Adhesion formation results from dysregulated peritoneal repair involving inflammation, coagulation-fibrinolysis imbalance, and fibroproliferative remodelling. Evidence suggests that endometriosis creates a peritoneal environment characterized by chronic inflammation, altered immune responses, repeated tissue injury, and exposure to menstrual debris and iron, which may promote adhesiogenesis. However, much mechanistic understanding is derived from experimental models, and direct evidence from patients remains limited. Prevention of adhesiogenesis in endometriosis currently focuses on intra-operative interventions to limit adhesion development following endometriosis-related surgery, rather than preventing disease-related adhesiogenesis in the absence of surgery. We discuss potential pharmacotherapies, including hormonal treatments, identified by experimental studies, which may perturb endometriosis-related adhesiogenesis.</p><p><strong>Wider implications: </strong>Current data support a model in which adhesion biology in endometriosis largely reflects conserved wound-healing pathways but develop within a chronically altered peritoneal microenvironment that lowers the threshold for adhesiogenesis and promotes persistence and recurrence. Clarifying endometriosis-specific drivers and generating robust human data are essential to develop targeted adhesion-prevention strategies and improve long-te","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":" ","pages":"779-804"},"PeriodicalIF":20.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731758/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148765637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the reproductive lifespan of female cancer survivors using AMH: a meta-synthesis of longitudinal studies. 使用AMH评估女性癌症幸存者的生殖寿命:纵向研究的综合。
IF 20.1 1区 医学
Human Reproduction Update Pub Date : 2026-11-01 DOI: 10.1093/humupd/dmag019
Neerujah Balachandren, Stavroula L Kastora, Richard A Anderson, Clara Luehwink, Melanie C Davies, Stuart A Lavery, Dimitrios Mavrelos, Ephia Yasmin
{"title":"Assessing the reproductive lifespan of female cancer survivors using AMH: a meta-synthesis of longitudinal studies.","authors":"Neerujah Balachandren, Stavroula L Kastora, Richard A Anderson, Clara Luehwink, Melanie C Davies, Stuart A Lavery, Dimitrios Mavrelos, Ephia Yasmin","doi":"10.1093/humupd/dmag019","DOIUrl":"10.1093/humupd/dmag019","url":null,"abstract":"<p><strong>Background: </strong>Anti-Müllerian hormone (AMH) is widely used to assess gonadotoxicity related to anti-cancer treatments and to measure ovarian function in cancer survivors. The extent of AMH decline across malignancies and treatment regimens and the degree of subsequent recovery have not been systematically quantified.</p><p><strong>Objective and rationale: </strong>The primary objective of this review was to quantify the change in AMH following cancer treatment and to model longitudinal AMH trajectories in survivors. The secondary objective was to compare AMH trajectories in cancer survivors with those of age-matched non-cancer controls. Data on long-term ovarian reserve after cancer treatment remain limited. This study integrates recent evidence and age-matched control data to better distinguish treatment-related AMH decline from normal reproductive ageing.</p><p><strong>Search methods: </strong>A systematic search was performed across CENTRAL, MEDLINE, Google Scholar, Embase, and MedRxiv from inception until 24 January 2024, with an updated search on 19 March 2026. Both MEDLINE and Embase were searched via the Ovid platform, whilst Emtree index terms were used for EMBASE. The search strategy combined both index terms and free-text terms: (gonadotoxicity OR premature menopause OR premature ovarian insufficiency (POI) OR premature ovarian failure (POF)) AND (AMH OR Antimullerian* OR Anti-Mullerian) AND cancer. Studies were included if they involved female cancer patients of any age, including paediatric, adolescent and young adult (AYA), and adult populations, who received chemotherapy and who reported either pre- and post-treatment AMH levels or AMH measurements at defined time points after treatment. Studies were excluded if they did not report quantitative AMH data, involved male patients or non-human subjects, or included studies unrelated to cancer treatment-induced gonadotoxicity. The primary outcome was percentage change in AMH from baseline to 12 and 24 months from the end of treatment. Secondary outcomes included long-term AMH trajectories in adult and paediatric cancer survivors compared to the age-related decline in healthy controls. Risk of bias was assessed using the Joanna Briggs Institute (JBI) study-design-specific critical appraisal tools, and certainty of evidence was evaluated using GRADE. Analyses were performed in GraphPad Prism v10.6.</p><p><strong>Outcomes: </strong>Across all four cohorts (breast, lymphoma, thyroid, and paediatric/AYA mixed cancers), AMH levels were higher at 12 and 24 months compared with 6 months from the end of treatment. With breast cancer (median age 37.8 years, n = 2259), AMH was reduced by 76.4% at 12 months (95% CI: -93.5 to -55.7; 24 studies; GRADE: moderate-certainty evidence). With lymphoma, ABVD treatment regimens (median age 24 years, n = 146) were associated with a smaller reduction in AMH at 12 months (-21.1%; 95% CI: -81.6 to +14.8; four studies; GRADE: low-certainty evidenc","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":" ","pages":"735-756"},"PeriodicalIF":20.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148585849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revisiting placental hypoxia in assisted reproduction: from molecular signatures to functional consequences. 重新审视辅助生殖中的胎盘缺氧:从分子特征到功能后果。
IF 20.1 1区 医学
Human Reproduction Update Pub Date : 2026-11-01 DOI: 10.1093/humupd/dmag025
Reza K Oqani, Emin Maltepe, Paolo Rinaudo
{"title":"Revisiting placental hypoxia in assisted reproduction: from molecular signatures to functional consequences.","authors":"Reza K Oqani, Emin Maltepe, Paolo Rinaudo","doi":"10.1093/humupd/dmag025","DOIUrl":"10.1093/humupd/dmag025","url":null,"abstract":"<p><strong>Background: </strong>The global expansion of assisted reproductive technologies (ART), including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), has raised concerns regarding the impact on placental development and susceptibility to pregnancy complications. Oxygen tension is a central regulator of placental biology, acting both as a physiological developmental signal and, when dysregulated, as a driver of pathology. Early placentation occurs in a naturally low-oxygen environment that is essential for trophoblast specification, invasion, immune-vascular crosstalk, and angiogenesis. These processes are coordinated by hypoxia-inducible factor (HIF) signaling and related oxygen-sensing pathways.</p><p><strong>Objective and rationale: </strong>This review examines the dual role of oxygen in placental development and disease, with particular emphasis on the molecular mechanisms that regulate hypoxia responses during normal and pathological placentation. We further evaluate emerging evidence that ART alters early embryonic and placental programming and propose a mechanistic framework in which ART-induced developmental reprogramming increases susceptibility to hypoxic maladaptation later in pregnancy.</p><p><strong>Search methods: </strong>Literature searches were conducted in PubMed and Google Scholar up to June 2026 using combinations of the terms 'hypoxia,' 'placenta,' 'HIF signaling,' 'assisted reproductive technology,' 'in vitro fertilization,' and 'embryo culture.' Studies were limited to English-language publications, with emphasis on human studies and mechanistic investigations in experimental animal and stem cell models.</p><p><strong>Outcomes: </strong>Oxygen tension emerges as a master regulator of placental development. Genetic and experimental studies demonstrate that precise temporal and spatial regulation of HIF signaling, including distinct contributions of HIF-1α and HIF-2α, is essential for trophoblast differentiation, placental morphogenesis, vascular development, and fetal viability. Physiological hypoxia orchestrates normal placentation, whereas sustained or dysregulated activation of hypoxia-responsive pathways contributes to an angiogenic imbalance, inflammation, oxidative stress, mitochondrial dysfunction, regulated cell death, and placental insufficiency. Increasing evidence suggests that ART may perturb this tightly regulated developmental program at its earliest stages. Exposure of preimplantation embryos to non-physiological culture conditions can alter their metabolic state, redox homeostasis, epigenetic regulation, and trophectoderm gene expression. These early perturbations may persist into placental development, resulting in impaired trophoblast differentiation and invasion, altered angiogenic signaling, and heightened sensitivity to hypoxic stress. Collectively, findings from experimental models, human placental studies, and emerging single-cell and spatial omics approaches support a m","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":" ","pages":"826-850"},"PeriodicalIF":20.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148802085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic architecture of endometriosis: risk factors, comorbidities and clinical implications. 子宫内膜异位症的遗传结构:危险因素、合并症和临床意义。
IF 20.1 1区 医学
Human Reproduction Update Pub Date : 2026-11-01 DOI: 10.1093/humupd/dmag023
Grant W Montgomery, Isabelle M McGrath, Michael Toft Overgaard, Mette Nyegaard, Sally Mortlock
{"title":"Genetic architecture of endometriosis: risk factors, comorbidities and clinical implications.","authors":"Grant W Montgomery, Isabelle M McGrath, Michael Toft Overgaard, Mette Nyegaard, Sally Mortlock","doi":"10.1093/humupd/dmag023","DOIUrl":"10.1093/humupd/dmag023","url":null,"abstract":"<p><strong>Background: </strong>In 1999, Dr Susan Treloar and colleagues conducted a landmark twin study in Australia and reported their estimate of 51% for the heritability of endometriosis. This important result led several groups to begin mapping genetic factors contributing to increased endometriosis risk. Despite early challenges, advances in genome-wide association studies (GWAS) have identified multiple genetic risk factors and some target genes implicated in follow-up studies on genetic regulation of transcription. Access to large publicly available genetic datasets and analysis with endometriosis GWAS results is also providing new opportunities to answer important questions about comorbid conditions associated with endometriosis and their implications for clinical practice.</p><p><strong>Objective and rationale: </strong>The objective of the review is to summarize the last 25 years of genetic studies in endometriosis, outline contributions to our understanding of the disease, and suggest future directions to accelerate biological insights from genetic studies to improve clinical outcomes.</p><p><strong>Search methods: </strong>A comprehensive review of scientific literature on the genetics of endometriosis was conducted through searches in PubMed and Google Scholar up to June 2026. Search terms included \"endometriosis AND (genetics OR GWAS OR genetic risk factors)\", For studies addressing the functional characterization of genetic risk loci, additional searches employed the terms \"endometriosis AND (genotype-phenotype associations OR colocalization OR eQTL OR mQTL OR multi omics methods)\". To identify studies examining shared genetic risk between endometriosis and comorbid conditions, the search strategy included \"endometriosis AND (genetic correlation OR colocalization OR Mendelian randomisation)\". Publications reporting discoveries related to genetic risk factors for endometriosis and studies interpreting their biological and clinical significance were critically evaluated, and 144 publications were discussed in the review.</p><p><strong>Outcomes: </strong>Discovery of genetic risk factors started slowly and has accelerated in recent years with developments in technology and international collaborations to combine data and increase statistical power. GWAS have mapped 80 genetic risk factors that implicate gene regulation of hormonal targets, development of the reproductive tract, regulation of cell proliferation, and regulation of epithelial cell differentiation. In common with most other complex diseases, effects of individual common genetic risk factors are small. However, several examples demonstrate that small effect sizes are not a good predictor for the impact of drugs developed against genetically validated targets. Genetic risk factors implicate five genes regulating gonadotrophin release and oestrogen action, the major target pathway of current drugs for treatment of endometriosis demonstrating proof-of-principal for biologica","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":" ","pages":"805-825"},"PeriodicalIF":20.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148893061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of mitochondrial dysfunction and genetics in female infertility and premature ovarian insufficiency. 线粒体功能障碍和遗传学在女性不育和卵巢功能不全中的作用。
IF 20.1 1区 医学
Human Reproduction Update Pub Date : 2026-11-01 DOI: 10.1093/humupd/dmag022
Brianna L Kline, Alison G Compton, Ann E Frazier, Svenja Pachernegg, Andrew H Sinclair, Katie L Ayers, Elena J Tucker
{"title":"The role of mitochondrial dysfunction and genetics in female infertility and premature ovarian insufficiency.","authors":"Brianna L Kline, Alison G Compton, Ann E Frazier, Svenja Pachernegg, Andrew H Sinclair, Katie L Ayers, Elena J Tucker","doi":"10.1093/humupd/dmag022","DOIUrl":"10.1093/humupd/dmag022","url":null,"abstract":"<p><strong>Background: </strong>Female infertility occurs in ∼37% of infertile couples, while premature ovarian insufficiency (POI) impacts 1-3.7% of women under the age of 40. POI is clinically heterogeneous, with various genetic pathways associated with its pathogenesis. Mitochondrial diseases (MDs) are a broad group of clinically heterogeneous genetic conditions characterized by aberrantly functioning mitochondria. MDs have a disproportionate burden on organs and tissues with increased aerobic/energy demands, such as the heart, skeletal muscles, brain, and ovaries. The role of mitochondria in female fertility and ovarian reserve is increasingly being recognized.</p><p><strong>Objective and rationale: </strong>A comprehensive understanding of the role of mitochondria in the maintenance of female fertility is pertinent to better understanding female reproductive potential. In a world with increasing demand for assisted reproductive technologies (ART), due to a considerable rate of global infertility, there is a need to better understand the genes and pathways involved in female reproduction. This review summarizes, evaluates, and explores the current knowledge of mitochondria-associated genes and variants that are implicated in POI, including their function and dysfunction in female reproduction.</p><p><strong>Search methods: </strong>We searched articles in the PubMed database, containing the following key words: premature ovarian insufficiency, mitochondria, mitochondrial, premature ovarian failure, genetics, mitochondrial DNA, mtDNA, mitochondrial protein, infertility, premature menopause, mitochondrial donation, assisted reproductive technologies, electron transport chain, oxidative phosphorylation (OXPHOS), mitochondrial disease, oocyte, oogenesis, meiosis, in vitro fertilization, mitoribosome, Perrault syndrome, and ovarioleukodystrophy, in the English-language literature until March 2026.</p><p><strong>Outcomes: </strong>Genetic variants that affect mitochondrial genes/proteins can negatively impact ovarian function. Various mitochondrial pathways are associated with female infertility, reflecting the broad sensitivity of ovarian reserve to mitochondrial dysfunction. Mitochondrial dysfunction and infertility can present in isolation or as part of a syndrome. Infertility in women may be the first clinical sign of a MD. Conversely, POI may be an underappreciated symptom of MDs.</p><p><strong>Wider implications: </strong>This review draws attention to the fact that females with MDs should be monitored for POI so it can be detected early for prompt and appropriate therapeutic interventions, such as hormone replacement therapy. This is known to mitigate the risk of comorbidities such as cardiovascular and bone disease and will optimize long-term health outcomes. Of equal importance, our review highlights the potential for girls and women presenting with apparently 'isolated' POI to harbour pathogenic variants in MD-associated genes, therefore ","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":" ","pages":"757-778"},"PeriodicalIF":20.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148802069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes and euploidy rates of embryos derived from zygotes with nonpronuclear (0PN) and monopronuclear (1PN) in IVF or ICSI cycles: a systematic review and meta-analysis. IVF或ICSI周期中非原核(0PN)和单核(1PN)受精卵衍生的胚胎的临床结果和整倍体率:系统回顾和荟萃分析
IF 20.1 1区 医学
Human Reproduction Update Pub Date : 2026-11-01 DOI: 10.1093/humupd/dmag015
Hoi Wing Chan, Chi Chiu Wang, David Yiu Leung Chan
{"title":"Clinical outcomes and euploidy rates of embryos derived from zygotes with nonpronuclear (0PN) and monopronuclear (1PN) in IVF or ICSI cycles: a systematic review and meta-analysis.","authors":"Hoi Wing Chan, Chi Chiu Wang, David Yiu Leung Chan","doi":"10.1093/humupd/dmag015","DOIUrl":"10.1093/humupd/dmag015","url":null,"abstract":"<p><strong>Background: </strong>During routine fertilization checks, the presence of two pronuclei (2PN) with two polar bodies is generally regarded as normal fertilization. Nonpronuclear (0PN) zygotes often suggest failed fertilization, but some do cleave and develop into viable embryos due to delayed appearances of pronuclei that were originally missed. Monopronuclear (1PN) zygotes may result from a lack of maternal or paternal pronuclei, fusion of pronuclei, or asynchronous appearance of pronuclei. These embryos may sometimes be transferred when no others are available.</p><p><strong>Objective and rationale: </strong>Current evidence on the euploidy rates (ER) and clinical outcomes of embryos derived from 0PN and 1PN zygotes is discordant across publications, resulting in conflicting conclusions regarding whether they are suitable for transfer. This review aims to present an updated synthesis of current knowledge regarding the potential adverse outcomes associated with 0PN and 1PN embryo transfers and to identify important gaps that should be addressed in future studies.</p><p><strong>Search methods: </strong>CENTRAL, Embase, Fertility and Sterility, MEDLINE, and PubMed databases were searched on 10 November 2025 using the keywords '0PN embryo' and '1PN embryo'. All types of studies, except case reports and reviews, were included if they compared 0PN/1PN with 2PN zygotes in women of any age undergoing IVF/ICSI cycles, followed by single embryo transfer (SET) and/or preimplantation genetic testing for aneuploidy (PGT-A). Pronuclear status was assessed 16-18 h post insemination. Only data from SET cycles were included for embryo transfer outcomes.</p><p><strong>Outcomes: </strong>Eleven studies reporting on 37 240 SET cycles and 27 195 biopsied blastocysts were included. Compared to 2PN embryos, those derived from 0PN zygotes showed no significant differences in live birth rate (LBR) (OR = 0.94, 95% CI = 0.83-1.06, P = 0.33, I2 = 2%), clinical pregnancy rate (CPR) (OR = 0.96, 95% CI = 0.85-1.08, P = 0.48, I2 = 0%), miscarriage rate (MR) (OR = 1.04, 95% CI = 0.84-1.29, P = 0.70, I2 = 0%), malformation rate (OR = 1.05, 95% CI = 0.45-2.45, P = 0.91, I2 = 0%), and ER (OR = 0.86, 95% CI = 0.50-1.48, P = 0.59, I2=63%). However 0PN-derived embryos had a significantly lower blastulation rate (OR = 0.34, 95% CI = 0.17-0.68, P = 0.002; I2 = 99%). Compared to 2PN, 1PN embryos showed a significantly lower LBR (OR = 0.83, 95% CI = 0.70-0.98, P = 0.03, I2 = 12%), CPR (OR = 0.81, 95% CI = 0.68-0.96, P = 0.01, I2 = 22%), and blastulation rate (OR = 0.26, 95% CI = 0.14-0.48, P < 0.001; I2 = 96%), but a similar MR (OR = 1.34, 95% CI = 0.76-2.37, P = 0.31, I2 = 67%), malformation rate (OR = 0.46, 95% CI = 0.16-1.32, P = 0.15, I2 = 0%), and ER (OR = 1.05, 95% CI = 0.70-1.58, P = 0.80, I2 = 66%).</p><p><strong>Wider implications: </strong>In the meta-analysis, both 0PN- and 1PN-derived embryos showed no significant differences in rates of euploidy, miscarriage, and ","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":" ","pages":"693-716"},"PeriodicalIF":20.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148165723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does time-lapse imaging (TLI) of embryos improve reproductive outcomes in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI)? Individual participant data (IPD) meta-analysis 胚胎延时成像(TLI)是否能改善体外受精(IVF)/胞浆内单精子注射(ICSI)的生殖结果?个体参与者数据(IPD)荟萃分析
IF 13.3 1区 医学
Human Reproduction Update Pub Date : 2026-10-29 DOI: 10.1093/humupd/dmag035
Priya Bhide, David Yiu Leung Chan, Dorit Christina Kieslinger, Angela Miranda-Segura, Aisling Ahlström, Patricia Fauque, Semra Kahraman, Khalid Saeed Khan, Peter Kovacs, Cornelis Lambalk, Kersti Lundin, Ge Lin, Miriam Mateos-Haro, Hannah Park, Shakila Thangaratinam, Carlijn Vergouw, Murong Xu, Madelon van Wely, Javier Zamora
{"title":"Does time-lapse imaging (TLI) of embryos improve reproductive outcomes in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI)? Individual participant data (IPD) meta-analysis","authors":"Priya Bhide, David Yiu Leung Chan, Dorit Christina Kieslinger, Angela Miranda-Segura, Aisling Ahlström, Patricia Fauque, Semra Kahraman, Khalid Saeed Khan, Peter Kovacs, Cornelis Lambalk, Kersti Lundin, Ge Lin, Miriam Mateos-Haro, Hannah Park, Shakila Thangaratinam, Carlijn Vergouw, Murong Xu, Madelon van Wely, Javier Zamora","doi":"10.1093/humupd/dmag035","DOIUrl":"https://doi.org/10.1093/humupd/dmag035","url":null,"abstract":"BACKGROUND Time‑lapse imaging (TLI) systems may improve the success of in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) by enabling undisturbed embryo culture and/or providing morphokinetic data to refine embryo selection. Despite several trials and aggregate meta-analyses showing uncertainty of benefit, there is little translation of evidence into guidelines. Heterogeneity in participant populations and algorithms used for TLI, although acknowledged in aggregate meta-analyses, remains unaddressed. OBJECTIVE AND RATIONALE We conducted an individual participant data (IPD) meta-analysis to assess whether TLI improves reproductive outcomes and if effects vary by women or intervention characteristics. Our IPD meta-analysis enhances statistical power, allowing precise estimation of treatment effects and identification of subgroup differences. It overcomes the limitations of aggregate meta-analyses by enabling harmonised adjustment by participant-level baseline risk, testing treatment–covariate interactions and provides a comprehensive evaluation of TLI by leveraging diverse datasets from multiple studies that assess both undisturbed culture and morphokinetic-based embryo selection. The study implements rigorous data integrity and consistency checks to enhance the reliability and trustworthiness of its findings. SEARCH METHODS We conducted an IPD meta-analysis of randomised controlled trials (RCTs) in women undergoing IVF/ICSI that used TLI systems. We evaluated overall TLI (undisturbed culture and morphokinetic-based embryo selection), undisturbed culture alone, and morphokinetic-based embryo selection alone. The primary outcome was live birth after a first fresh or frozen embryo transfer; other outcomes included clinical pregnancy, biochemical pregnancy loss, miscarriage, multiple pregnancy, minor and major congenital malformations, birth weight, and gestational age at birth. We included trials from the 2019 Cochrane review and updated searches of MEDLINE, EMBASE, CINAHL, and CENTRAL from 7 January 2019 to 9 May 2025 and repeated the search on 28 July 2026. We requested IPD from the authors of included trials. We assessed study-level risk of bias using the revised Cochrane risk-of-bias tool for RCTs (ROB2) and undertook integrity assessment of included studies. We performed a two-stage IPD meta-analysis. Results are presented as adjusted odds ratios (aOR) with 95% confidence intervals and adjusted absolute risk difference (aRD) estimates in a modified intention-to-treat population with pre-specified subgroup and sensitivity analyses. OUTCOMES We included IPD from eight trials (n = 5642) for the primary analysis and added aggregate data from eight trials (n = 3452) for a sensitivity analysis. ROB2 assessment raised no concerns with the IPD-included trials. High-certainty evidence indicated no clinically important difference in live birth rates for overall TLI versus standard embryo incubation and selection (four trials, n = 2913, a","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":"1 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149292990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaginal microbiome composition and medically assisted reproduction outcomes: a systematic review and network meta-analysis of 2289 women across three WHO regions. 阴道微生物组组成和医学辅助生殖结果:对世卫组织三个区域2289名妇女的系统评价和网络荟萃分析
IF 20.1 1区 医学
Human Reproduction Update Pub Date : 2026-10-15 DOI: 10.1093/humupd/dmag033
Hana Shabana, Unnur Gudnadottir, Luisa Warchavchik Hugerth, Kenny A Rodriguez-Wallberg, Nele Brusselaers
{"title":"Vaginal microbiome composition and medically assisted reproduction outcomes: a systematic review and network meta-analysis of 2289 women across three WHO regions.","authors":"Hana Shabana, Unnur Gudnadottir, Luisa Warchavchik Hugerth, Kenny A Rodriguez-Wallberg, Nele Brusselaers","doi":"10.1093/humupd/dmag033","DOIUrl":"https://doi.org/10.1093/humupd/dmag033","url":null,"abstract":"<p><strong>Background: </strong>The vaginal microbiome may influence the success of medically assisted reproduction (MAR), including IVF with or without ICSI, and IUI. However, findings across studies remain inconsistent, and previous meta-analyses have largely relied on binary microbiome classifications or pairwise comparisons. The relative associations between individual vaginal community state types (CSTs) and pregnancy outcomes therefore remain uncertain.</p><p><strong>Objective and rationale: </strong>To compare the associations between individual CSTs and pregnancy following MAR by integrating direct and indirect evidence in a systematic review and network meta-analysis (NMA) and to determine whether specific CSTs were associated with lower odds of pregnancy.</p><p><strong>Search methods: </strong>PubMed, Embase, Web of Science, and the Cochrane Library were searched from database inception to 2 April 2026. Eligible longitudinal studies assessed vaginal microbiome composition using sequencing-based profiling before embryo transfer or IUI and reported pregnancy following MAR. Cross-sectional studies, studies without CST classification, or pregnancy outcome data, and studies based solely on post-treatment sampling were excluded. Two reviewers independently performed study selection and risk-of-bias assessment. Odds ratios (ORs) with 95% CIs were synthesized across CSTs using NMA. Twelve longitudinal studies including 2289 women met the inclusion criteria. The prospectively registered review was reported in accordance with PRISMA and the PRISMA extension for NMA.</p><p><strong>Outcomes: </strong>The NMA allowed integration of direct and indirect evidence across six CST categories. Compared with Lactobacillus (L.) crispatus, Lactobacillus jensenii-dominated CSTs (OR 0.42, 95% CI 0.19-0.92), and low-lactobacillus community CSTs (OR 0.59, 95% CI 0.38-0.91) were associated with significantly lower odds of pregnancy. No statistically significant differences were observed for other lactobacilli, including Lactobacillus gasseri and Lactobacillus iners, compared with L. crispatus. Tests found no evidence of overall or loop inconsistency in the primary network. Subgroup analyses showed broadly similar patterns but were limited by sparse data, imprecision, and local inconsistency in some subgroup networks. Interpretation was further limited by clinical and methodological heterogeneity, observational study designs, residual confounding, and sparse evidence for several CST comparisons. Live-birth evidence was particularly limited: only five studies reported a total of 57 live births. Transitivity could not be formally assessed because potential effect modifiers were not consistently reported for individual CSTs.</p><p><strong>Wider implications: </strong>The findings indicate that general assumption of Lactobacillus-dominated CSTs being beneficial to MAR-treatment effects should be regarded with caution, as these may differ in their associations with preg","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":" ","pages":""},"PeriodicalIF":20.1,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149197800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书